Decompressive Craniectomy Following Trauma

Sponsor
Assiut University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT04574349
Collaborator
(none)
20
1
12
1.7

Study Details

Study Description

Brief Summary

A prospective clinical trial on trauma patients with increased intracranial pressure(ICP) applied for decompressive craniectomy to lower ICP

Condition or Disease Intervention/Treatment Phase
  • Procedure: Decompressive craniectomy
N/A

Detailed Description

Traumatic brain injury (TBI) remains a major health problem across the globe . Intracranial pressure (ICP) following TBI can be elevated due to increasing mass effect from hematomas, contusions, and diffuse brain swelling. Decompressive craniectomy (DC) is a surgical procedure which involves removing a large part of the skull (bone flap) out to make more room for the swollen brain.Mass lesions can be acute subdural hematoma (ASDH), intraparenchymal, brain oedema, or a combination thereof. The most frequent indication for a DC is an acute subdural hematoma (ASDH). The first modern use of DC following TBI was done by Harvey Cushing in 1908. Cushing treated head-injured patients with a subtemporal DC and he reported a substantial reduction in mortality. The management of TBI progressed significantly in the 21st century due to advances in neuroimaging, prehospital management, neurointensive care, neuroanaesthesia, and rehabilitation. This led to a renaissance of interest in DC for improvement patient conditions. One of the serious concerns regarding DC is that it may reduce mortality, but increase the subset of patients with severe disability and persistent vegetative state. The discrepancy in published outcome may, to some extent, be explained by difference in patient selection, indications, timing , and technique of surgery. In terms of surgical consideration regarding DC, it is now well accepted that the dura mater has to be opened and the minimum diameter of unilateral DC should be around 11-12 cm. Skull reconstruction (cranioplasty) after improvement of neurological state is recommended. Decompressive craniectomy provides additional space for the swollen brain and can effectively reduce ICP, thereby mitigating the risk of herniation. However, despite the positive effect of DC on uncontrollable intracranial hypertension, the effect of surgical decompression in mortality and overall functional outcome following TBI remained controversial.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
20 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Effect of Decompressive Craniectomy Following Traumatic Brain Injury: One Year Study
Anticipated Study Start Date :
Oct 1, 2020
Anticipated Primary Completion Date :
Oct 1, 2021
Anticipated Study Completion Date :
Oct 1, 2021

Outcome Measures

Primary Outcome Measures

  1. Change of the patient's condition clinically [one year]

    Clinically: Change of Glasgow Coma Scale (GCS). Maximum value is 15 Minimum value is 3

  2. Change of the patient's condition radiologically [One year]

    By CT brain

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A to 60 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • All Patients with signs of increased intracranial tension (subdural hematoma, brain edema, intracerebral hematoma) after trauma diagnosed clinically, radiologically, and resistant to medical decompression.

  • Age: up to 60

  • Midline shift more than 5 mm.

  • GCS > 8

Exclusion Criteria:
  • Age: more than 60

  • Old trauma

  • Unfit for surgery (ex: cardiac patient)

  • GCS < 8

  • Midline shift less than 5 mm.

  • Unwillingness to participate in the study.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Assiut University Assiut Egypt

Sponsors and Collaborators

  • Assiut University

Investigators

  • Principal Investigator: Roshdy A Elkhayat, Professor, Assiut University

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Alaa Eldeen Mohamed Oreaby Adam, Assistant Lecturer at neurosurgery department, Assiut University, Assiut University
ClinicalTrials.gov Identifier:
NCT04574349
Other Study ID Numbers:
  • Decompressive craniectomy
First Posted:
Oct 5, 2020
Last Update Posted:
Oct 5, 2020
Last Verified:
Sep 1, 2020
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 5, 2020